171 parallel-and-distributed-computing-"Multiple" positions at Technical University of Munich
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
systems involved in an effective health care system, rather than creating new medical treatments. Our recent studies have been motivated by two parallel questions: How can we encourage people to engage with
-
junior research group leader with a focus on data and AI Science to join us as soon as possible. Your qualifications PhD in Computer Science, Mathematics, Physics or related fields Experience in applied
-
/d) in Energy Informatics. You are passionate about applying cutting-edge information technology to solve the energy and climate crisis and would like to work in a vibrant and international research
-
18.09.2024, Wissenschaftliches Personal We have several 𝐏𝐡𝐃 & 𝐏𝐨𝐬𝐭𝐃𝐨𝐜 𝐨𝐩𝐞𝐧𝐢𝐧𝐠𝐬 in our Visual Computing & AI Lab in Munich! Topics have a strong focus on GenAI, including 3DGs
-
of distributed computing, machine learning, image and text analysis, randomized data structures, high-performance computing, and quantum algorithms. Beyond this research, we aim to support computational thinking
-
, transcriptomic, and proteomic approaches. In parallel, engineered Aspergillus niger strains will be developed for the sustainable production of selected pigments as dyes, which will be further scaled up
-
“Commended Paper Award” of the IFAC MIM conference. Prof. Otto actively engages in academic governance, serving as an editorial board member of leading scientific journals as well as a program committee member
-
, equitable, trustworthy, and context-sensitive. Multi-agent architectures where multiple AI systems collaborate, negotiate, and adapt to model complex human learning processes and support group work
-
supporting multiple sensors (LiDAR, radar, camera) for dynamic environments like ports, airports, and logistics hubs. Optimize algorithms for real-time operation on edge devices with limited computational
-
) in an experimental model of multiple sclerosis (MS). This project builds on recent findings from the phase III Hercules trial (Fox et al., NEJM 2025) showing therapeutic effects of BTK inhibition in